groupp < groups < grow

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 115.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000004 (1979)	W. M. Marine ; J. E. Thomas	Antigenic memory to influenza A viruses in man determined by monovalent vaccines.
000014 (1998)	A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]	Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
000017 (1973)	Steven R. Mostow ; Stephen C. Schoenbaum ; Walter R. Dowdle ; Marion T. Coleman ; Harold S. Kaye	Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation
000030 (1975)	Susan B. Spring [États-Unis] ; Sandra R. Nusinoff [États-Unis] ; John V. Mills [États-Unis] ; Douglas D. Richman [États-Unis] ; Eveline L. Tierney [États-Unis] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]	Temperature-sensitive mutants of influenza virus
000032 (1987)	N. Masurel [Pays-Bas]	Influenza A and B antibody status in Tanzania
000052 (1980)	R. A. Heijtink [Pays-Bas] ; N. Masurel [Pays-Bas] ; W. Weimar [Pays-Bas] ; S. W. Schalm [Pays-Bas]	Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon
000053 (1980)	N. J. Dimmock [Royaume-Uni] ; A. S. Carver [Royaume-Uni] ; R. G. Webster [États-Unis]	Categorization of nucleoproteins and matrix proteins from type A influenza viruses by peptide mapping
000063 (1977)	S. B. Spring [États-Unis] ; H. F. Maassab [États-Unis] ; A. P. Kendal [États-Unis] ; B. R. Murphy [États-Unis] ; R. M. Chanock [États-Unis]	Cold-adapted variants of influenza virus A
000076 (1993)	Richard Thomas	SOURCE REGION EFFECTS IN EPIDEMIC DISEASE MODELING: COMPARISONS BETWEEN INFLUENZA AND HIV
000081 (1973)	William M. Marine ; James E. Thomas	Age-related response to 1000 CCA unit zonally purified, inactivated influenza vaccines in volunteers in the U.S.A
000086 (1999)	Hunein F. Maassab [États-Unis] ; Martin L. Bryant [États-Unis]	The development of live attenuated cold‐adapted influenza virus vaccine for humans
000090 (1986)	G. I. Alexandrova [Russie] ; G. N. Budilovsky [Russie] ; T. A. Koval [Russie] ; F. I. Polezhaev [Russie] ; L. M. Garmashova [Russie] ; Yu. Z. Ghendon [Russie] ; Y. R. Romanova [Russie] ; A. A. Smorodintsev [Russie]	Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial
000112 (2001)	L. G Rudenko [Russie] ; G. I Alexandrova [Russie]	Current strategies for the prevention of influenza by the Russian cold-adapted live influenza vaccine among different populations
000123 (1994)	O. B. Romanova [Russie] ; T. V. Ivanyuk [Russie] ; A. V. Kadushkin [Russie] ; N. I. Fadeeva [Russie] ; I. A. Leneva [Russie] ; I. S. Nikolaeva [Russie] ; V. S. Peters [Russie] ; L. Yu. Krylova [Russie] ; T. A. Gus'Kova [Russie] ; V. G. Granik [Russie]	Synthesis and study of the antiviral activity of enaminoketones substituted on nitrogen with hydroxyl-containing groups
000146 (1998)	E. H. Soumhi [Tunisie] ; I. Saadoune [Tunisie] ; A. Driss [Tunisie] ; T. Jouini [Tunisie]	Structure of (C3H5NH3)2H2P2O7·H2O
000154 (1988)	O. P. Zhirnov [Russie]	The host origin of influenza A viruses can be assessed by the intracellular cleavage of the viral nucleocapsid protein
000157 (1976)	Goronwy O. Broun Sr. [États-Unis] ; Dennis O'Connor [États-Unis] ; Rose Rita Schmidt [États-Unis] ; Barbara Puder [États-Unis]	Factors involved in immunization program for swine influenza
000164 (2012)	Peter Vranec [Slovaquie] ; Ivan Poto K [Slovaquie] ; Peter Repovsk [Slovaquie]	Low‐dimensional compounds containing bioactive ligands. IV. Unusual ionic forms of 5‐chloroquinolin‐8‐ol
000176 (2001)	George Stamatiou [Grèce] ; Antonios Kolocouris [Grèce] ; Nicolas Kolocouris [Grèce] ; George Fytas [Grèce] ; George B. Foscolos [Grèce] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique]	Novel 3-(2-Adamantyl)pyrrolidines with potent activity against influenza A virus—identification of aminoadamantane derivatives bearing two pharmacophoric amine groups
000182 (2001)	D. L Major [Royaume-Uni] ; R. W Newman [Royaume-Uni] ; U. Dunleavy [Royaume-Uni] ; A. B Heath [Royaume-Uni] ; K. Ploss [Royaume-Uni] ; J. M Wood [Royaume-Uni]	Evaluation of H9N2 influenza vaccines in Balb/c mice
000186 (1983)	C. W. Potter [Royaume-Uni] ; R. Jennings [Royaume-Uni] ; A. Clark [Royaume-Uni] ; M. Ali [Royaume-Uni]	Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "groups" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "groups" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    groups
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021